These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 33084621

  • 1. Bromelain: A Review on its Potential as a Therapy for the Management of Covid-19.
    Owoyele BV, Bakare AO, Ologe MO.
    Niger J Physiol Sci; 2020 Jun 30; 35(1):10-19. PubMed ID: 33084621
    [Abstract] [Full Text] [Related]

  • 2. Cautions and Opportunities for Botanicals in COVID-19 Patients: A Comment on the Position of the French Agency for Food, Environmental and Occupational Health & Safety.
    Firenzuoli F, Antonelli M, Donelli D, Gensini GF, Maggini V.
    J Altern Complement Med; 2020 Oct 30; 26(10):851-853. PubMed ID: 32960104
    [No Abstract] [Full Text] [Related]

  • 3. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S, Saulnier A, Gatignol A.
    Virologie (Montrouge); 2020 Jun 01; 24(3):135-141. PubMed ID: 32648548
    [No Abstract] [Full Text] [Related]

  • 4. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.
    DiNicolantonio JJ, Barroso J, McCarty M.
    Open Heart; 2020 Sep 01; 7(2):. PubMed ID: 32895293
    [No Abstract] [Full Text] [Related]

  • 5. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
    Shahzad F, Anderson D, Najafzadeh M.
    Nutrients; 2020 Aug 25; 12(9):. PubMed ID: 32854262
    [Abstract] [Full Text] [Related]

  • 6. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA, Rezai S, Cleland E, Henderson CE.
    Rev Med Virol; 2020 Sep 25; 30(5):e2136. PubMed ID: 32644275
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG, Mohammed S, Elgendy IY.
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep 01; 6(5):333-334. PubMed ID: 32379307
    [No Abstract] [Full Text] [Related]

  • 9. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
    Beyazit F, Beyazit Y, Tanoglu A, Haznedaroglu IC.
    Med Hypotheses; 2020 Oct 01; 143():110150. PubMed ID: 32763660
    [Abstract] [Full Text] [Related]

  • 10. Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules.
    Prasad A, Muthamilarasan M, Prasad M.
    Plant Cell Rep; 2020 Sep 01; 39(9):1109-1114. PubMed ID: 32561979
    [Abstract] [Full Text] [Related]

  • 11. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
    El-Missiry MA, El-Missiry ZMA, Othman AI.
    Eur J Pharmacol; 2020 Sep 05; 882():173329. PubMed ID: 32615182
    [Abstract] [Full Text] [Related]

  • 12. [Characteristics of SARS-CoV-2 and potential pharmacological treatment].
    Pawlik L, Śpiołek E, Fichna J, Tarasiuk A.
    Postepy Biochem; 2020 May 09; 66(2):83-90. PubMed ID: 32700510
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations.
    Ji P, Chen J, Golding A, Nikolov NP, Saluja B, Ren YR, Sahajwalla CG.
    J Clin Pharmacol; 2020 Oct 09; 60(10):1275-1293. PubMed ID: 32779201
    [Abstract] [Full Text] [Related]

  • 15. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
    Bifulco M, Gazzerro P.
    Pharmacol Res; 2020 Jun 09; 156():104803. PubMed ID: 32289478
    [No Abstract] [Full Text] [Related]

  • 16. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
    Saul S, Einav S.
    ACS Infect Dis; 2020 Sep 11; 6(9):2304-2318. PubMed ID: 32687696
    [Abstract] [Full Text] [Related]

  • 17. Audio Interview: Tocilizumab and Covid-19.
    Rubin EJ, Baden LR, Morrissey S.
    N Engl J Med; 2020 Oct 22; 383(17):e114. PubMed ID: 33085870
    [No Abstract] [Full Text] [Related]

  • 18. East meets West in COVID-19 therapeutics.
    Wang S, Zeng X, Wang Y, Zhao Y, Chen W, Chen YZ.
    Pharmacol Res; 2020 Sep 22; 159():105008. PubMed ID: 32531323
    [No Abstract] [Full Text] [Related]

  • 19. Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.
    Bahrami M, Kamalinejad M, Latifi SA, Seif F, Dadmehr M.
    Phytother Res; 2020 Oct 22; 34(10):2429-2430. PubMed ID: 32472655
    [Abstract] [Full Text] [Related]

  • 20. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC.
    J Thromb Thrombolysis; 2020 Jul 22; 50(1):54-67. PubMed ID: 32415579
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.